| 标题 |
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:François‐Clément Bidard; Anne‐Claire Hardy‐Bessard; Florence Dalenc; Thomas Bachelot; Jean‐Yves Pierga; et al 出版日期:2022-09-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)